This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cao, W. M. Articles by Ishida, T. Search for Related Content PubMed PubMed Citation Articles by Cao, W. M. Articles by Ishida, T.

A Mutant High-Density Lipoprotein Receptor Inhibits Proliferation of Human Breast Cancer Cells

¹ First Department of Internal Medicine,² Second Department of Surgery, and³ Laboratory Medicine, Kagawa Medical University, Kagawa, Japan;⁴ Kuma Hospital, Kobe, Japan; and Departments of⁵ Medicine and⁶ Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Health Sciences Center, Calgary, Alberta, Canada

High-density lipoprotein (HDL) stimulates the growth of many types of cells, including those of breast cancer. High levels of HDL are associated with an increased risk of breast cancer development. A scavenger receptor of the B class (SR-BI)/human homolog of SR-BI, CD36, and LIMPII analogous-1 (CLA-1) facilitates the cellular uptake of cholesterol from HDL and thus augments cell growth. Furthermore, HDL is also believed to have antiapoptotic effects on various cell types, and this feature adds to its ability to promote cell growth. These collaborative roles of HDL and CLA-1 prompted us to assess the function of these components on human breast cancer cells. In this study, we created a mutant CLA-1 (mCLA) that lacked the COOH-terminal tail to determine its potential role in breast cancer cell growth. Expression of mCLA inhibited the proliferation of breast cancer cell line MCF-7. This inhibitory action of mCLA required the transcriptional factor activator protein-1 (AP-1), and the mutant receptor also affected the antiapoptotic features of HDL. The effect of HDL on AP-1 activation and [³H]thymidine incorporation was abrogated by wortmannin, a specific inhibitor of phosphoinositide 3-kinase. Furthermore, the dominant negative mutant of Akt abolished the ability of HDL to activate AP-1. These findings raise the possibility that the inhibitors of the effects of HDL may be of therapeutic value for breast cancer.

This article has been cited by other articles:

				V. G. Oehler, K. Y. Yeung, Y. E. Choi, R. E. Bumgarner, A. E. Raftery, and J. P. Radich The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data Blood, October 8, 2009; 114(15): 3292 - 3298. [Abstract] [Full Text] [PDF]

				Y. Kim, S. K. Park, W. Han, D.-H. Kim, Y.-C. Hong, E. H. Ha, S.-H. Ahn, D.-Y. Noh, D. Kang, and K.-Y. Yoo Serum High-Density Lipoprotein Cholesterol and Breast Cancer Risk by Menopausal Status, Body Mass Index, and Hormonal Receptor in Korea Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 508 - 515. [Abstract] [Full Text] [PDF]

				K. Murao, H. Imachi, X. Yu, W. M. Cao, T. Muraoka, H. Dobashi, N. Hosomi, R. Haba, H. Iwama, and T. Ishida The Transcriptional Factor Prolactin Regulatory Element-Binding Protein Mediates the Gene Transcription of Adrenal Scavenger Receptor Class B Type I via 3',5'-Cyclic Adenosine 5'-Monophosphate Endocrinology, December 1, 2008; 149(12): 6103 - 6112. [Abstract] [Full Text] [PDF]

				X. Zhang, A. N. Moor, K. A. Merkler, Q. Liu, and M. P. McLean Regulation of Alternative Splicing of Liver Scavenger Receptor Class B Gene by Estrogen and the Involved Regulatory Splicing Factors Endocrinology, November 1, 2007; 148(11): 5295 - 5304. [Abstract] [Full Text] [PDF]

				Y. Iwasaki, M. Nishiyama, T. Taguchi, M. Kambayashi, M. Asai, M. Yoshida, T. Nigawara, and K. Hashimoto Activation of AMP-activated protein kinase stimulates proopiomelanocortin gene transcription in AtT20 corticotroph cells Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1899 - E1905. [Abstract] [Full Text] [PDF]

				X. Yu, K. Murao, H. Imachi, W.-M. Cao, J. Li, K. Matsumoto, T. Nishiuchi, R. A.M. Ahmed, N. C.W. Wong, H. Kosaka, et al. Regulation of Scavenger Receptor Class BI Gene Expression by Angiotensin II in Vascular Endothelial Cells Hypertension, June 1, 2007; 49(6): 1378 - 1384. [Abstract] [Full Text] [PDF]

				Y. Zhang, A. M. Ahmed, N. McFarlane, C. Capone, D. R. Boreham, R. Truant, S. A. Igdoura, and B. L. Trigatti Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways J. Lipid Res., February 1, 2007; 48(2): 405 - 416. [Abstract] [Full Text] [PDF]

				M. R. Goldstein, K. Murao, H. Imachi, T. Ishida, and N. C. W. Wong Lipid-Altering Drugs: Decreasing Cardiovascular Disease at the Expense of Increasing Cancer? Cancer Res., September 15, 2004; 64(18): 6831 - 6832. [Full Text] [PDF]